Calcium Dobesilate Capsules

This product regulates the physiological function of the microvascular wall, reduces plasma viscosity, reduces platelet aggregation and other mechanisms, thereby regulating microcirculation function and playing a role in treating retinal microcirculation lesions caused by diabetes.

The main ingredient of this product is calcium dobesilate.

This product is a capsule, the contents are white or off-white granules, odorless and bitter.

Used for diabetic retinopathy.

Swallow with meals. During the initial treatment phase, take 1 tablet 3 times a day. After 4 to 6 weeks, adjust to 1 tablet 2 times a day.

Occasionally, symptoms such as stomach discomfort, nausea, heartburn, and lack of appetite may occur; in this case, the dosage should be reduced as appropriate and administration should be suspended if necessary.

It is contraindicated for those with gastrointestinal dysfunction or allergies.

Precautions for children: Safety data for children has not been established. Precautions for pregnancy and lactation: Calcium isethionate has no teratogenic effect in experimental studies and cannot cross the placenta. For the sake of caution, do not use it in the first three months of pregnancy and during lactation. Precautions for the elderly: This product is suitable for elderly patients, and data on dosage adjustment due to age have not been established.

This product needs to be used in combination with hypoglycemic drugs. Consult a physician before using this product for the first time. Regular hospital check-ups are required during treatment. It is not recommended for women in the first 3 months of pregnancy and during breastfeeding. It is contraindicated for those who are allergic to this product, and should be used with caution by those with allergic constitutions. It is prohibited to use this product when its properties change. Keep this product out of reach of children. If you are using other medicines, please consult a physician or pharmacist before using this product.

seal.

0.25g/tablet

Tentative 24 months

Kangya of Ningxia Pharmaceutical Co., Ltd.

• Founded in:

  1996-09-28

• Address:

  No. 57, Fu'an West Lane, Ning'an Street, Jinfeng District, Yinchuan City

• Tax NO.:

  916411002277485589

• Registered Funds:

  64.259672 million yuan

• Website:

  Log in to view

• Email:

  Log in to view